HopeStage
Back to all studies
RecruitingNCT07216404

Psilocybin-assisted therapy for depression in people with lung cancer

About this titleRead the official source — NCT07216404

This study evaluates the safety and effectiveness of Psilocybin for people with depression.

Medication studyAges 18+United States
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of Psilocybin for people with depression.

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
ColumbusSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
10
Sponsor
Alan Davis
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other, Procedure
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07216404
Official title
Show the full official title

Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)

Recruitment & locations

Currently recruiting

Columbus

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of Psilocybin for people with depression.

Who is behind this study?

The study sponsor is Alan Davis.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies